Notice of Clinical Trial Approval for Recombinant Human Adenovirus 5 Injection of Shanghai Pharmaceuticals Group Co., Ltd. Restructuring

Notice of Clinical Trial Approval for Recombinant Human Adenovirus 5 Injection of Shanghai Pharmaceuticals Group Co., Ltd. Restructuring

Recombinant human adenovirus type 5 injection (trade name: Ankrui) is an oncolytic adenovirus anti-tumor drug that contains recombinant adenoviruses that can specifically replicate in tumor cells, cause tumor cell damage, lysis, and further activate immune responses to exert anti-tumor effects. Ankeri was approved for marketing in China in 2005, with an approved indication for advanced nasopharyngeal carcinoma...

Microorganisms are expected to become a weapon against cancer! Related drugs have entered clinical trials

Microorganisms are expected to become a weapon against cancer! Related drugs have entered clinical trials

Reporter of Science and Technology Daily Liu XiaSalmonella usually causes food poisoning, but in 2019, 71 year old Canadian Irit Barbour volunteered to drink a bottle of liquid containing 1 billion active Salmonella typhimurium as the last resort to fight pancreatic cancer. At that time, pancreatic cancer had spread to other organs in her body, and she could only live for a few months...

Strong demand in the global photovoltaic market, Chinese enterprises actively layout overseas industrial chains

Strong demand in the global photovoltaic market, Chinese enterprises actively layout overseas industrial chains

Guangzhou, July 8th (Reporter Cai Minjie) This year, the global photovoltaic market demand has remained strong. China is the largest market for photovoltaic applications and also the world's largest manufacturing base...

2023 World Artificial Intelligence Conference Closes and Promotes Signing of 32 Major Industrial Projects

2023 World Artificial Intelligence Conference Closes and Promotes Signing of 32 Major Industrial Projects

On July 8th, the 2023 World Artificial Intelligence Conference, with the theme of "Smart Connect the World, Generate the Future", closed at the World Expo Center. The closing ceremony gave a wonderful review of the 2023 World Artificial Intelligence Conference...

Human tooth regeneration is not a dream? The world's first

Human tooth regeneration is not a dream? The world's first "tooth regeneration" drug will undergo clinical trials

For humans, teeth are a very precious organ. In nature, fierce animals like big sharks constantly change their teeth throughout their lives, while humans only have two opportunities to grow teeth in their lifetime, one is deciduous and the other is permanent...

TCL releases the

TCL releases the "3050" carbon neutrality target and action plan to promote the construction of a green and sustainable industrial ecosystem

Global Network Technology Comprehensive ReportOn July 6th, during the 2023 TCL Global Ecological Partnership Conference (GPC2023), TCL officially released a carbon neutrality white paper and officially announced the Enterprise Carbon Neutrality Action Plan TCLGreen, setting the "3050" commitment goal of "achieving carbon peak no later than 2030 and carbon neutrality no later than 2050". At the same time, TCL announced important achievements in technological innovation, standard formulation, industrial alliances, strategic cooperation, and other fields since the launch of the global ecological cooperation development strategy "Sunrise Plan" two years ago...

Huang Qifan: The new generation of

Huang Qifan: The new generation of "five major pieces" will become the main battlefield of global industrial competition!

Looking back at economic history, each era's trend has given rise to several durable consumer goods worldwide. From bicycles, sewing machines, radios, to televisions, refrigerators, washing machines, to computers, LCD TVs, mobile phones, etc...

The Gates Foundation announced its support for the launch of phase III clinical trial of tuberculosis candidate vaccine

The Gates Foundation announced its support for the launch of phase III clinical trial of tuberculosis candidate vaccine

On June 28, the Wellcome Trust and the Bill and Melinda French Gates Foundation announced that they would provide funds to support the phase III clinical trial of tuberculosis candidate vaccine M72/AS01E (M72). If proved effective, M72 is expected to become the first new vaccine to prevent tuberculosis since the BCG vaccine vaccine was introduced in 1921...

China's first, successful sea trial!

China's first, successful sea trial!

On June 27, according to the information of Offshore Petroleum engineering Co., Ltd,The first 2500 meter level ultra deep water pile hammer independently developed by China has successfully completed sea trials, filling the technical gap in the core equipment of ultra deep water pile driving in China...

Indonesia's Yawan High Speed Rail Joint Debugging and Trial Speed Reaches 350 kilometers per hour

Indonesia's Yawan High Speed Rail Joint Debugging and Trial Speed Reaches 350 kilometers per hour

According to Xinhua News Agency, Jakarta, June 22 (Xinhua) (Reporter Yu Qianliang, Wang Ona) The comprehensive testing of the joint debugging and testing of Indonesia's Yawan High Speed Railway reached a speed of 350 kilometers per hour for the first time on the 22nd, marking that the Yawan High Speed Railway has reached the design speed standard and achieved the phased task goal of joint debugging and testing.Since the joint commissioning and test of Ya'an Wanzhou High speed Railway was officially started on May 22, China Railway International Co...

Chief Scientist Zhang Hong:

Chief Scientist Zhang Hong: "Four Modernizations" Development Helps Bridge Industrialization Upgrade

Science and Technology Daily reporter Wu Chunxin, Fu Yifei, correspondent Zhou XuanOn June 16th, at the parallel forum of the 2023 World Transportation Congress, "Intelligent Construction Forum for Industrialization of Transportation Infrastructure", Zhang Hong, Chief Director of China Communications Group and Chief Scientist of China Communications Second Navigation Bureau, mentioned in the theme report that the complete set of technology and equipment for industrialized intelligent construction of steel reinforcement components, which combines the advantages of industrialization, digitization, networking, and intelligence, has received widespread attention from attendees. It is worth mentioning that Zhang Hong proposed solutions in the report to address the challenges of low efficiency, high labor demand, high safety risks, and difficult engineering quality control in traditional steel bar construction...

Guo Xueping, Chief Scientist of Huaxi Biology: Synthetic Biology is embarking on a new journey of raw material and industrial transformation

Guo Xueping, Chief Scientist of Huaxi Biology: Synthetic Biology is embarking on a new journey of raw material and industrial transformation

On June 3, 2023, the China (Jinan) Hyaluronic Acid Industry Conference, with the theme of "Technology Building and Innovation Leading", was grandly opened in Jinan, Shandong. At the same time, the "Conference on Cell Factories and Functional Sugar Biomanufacturing" and the 4th Bioactive Substances Series Conference were also held with great success...